
华盛顿 —— 食品药品监督管理局(FDA)预计将在3月完成对堕胎药米非司酮的安全性审查,这将是该机构多年来面临的最具政治敏感性的决定之一。然而,届时该机构可能仍没有常任负责人来监督这一工作。唐纳德·特朗普总统提名的机构负责人人选、海迪·奥弗顿博士将于下周在健康、教育、劳工和养老金委员会面临表决,但她所需的几位关键共和党参议员的支持仍未定,而民主党将在几周后接管参议院控制权。
WASHINGTON — The Food and Drug Administration is set to finish its safety review of the abortion pill mifepristone in March, setting up one of the most politically charged decisions the agency has faced in years. And yet it may not have a permanent leader to oversee it. Dr. Heidi Overton, President Donald Trump’s pick to run the agency, faces a vote next week before the Health, Education, Labor and Pensions Committee, but key Republicans whose support she needs remain uncommitted, with only weeks before Democrats take control of the Senate.
“我还没有表态,”缅因州参议员苏珊·柯林斯周四在国会山接受简短采访时表示,并补充说她需要“就各种问题获得一些答复”。阿拉斯加参议员丽莎·穆尔科斯基拒绝透露她将如何投票。在9月的提名听证会上,穆尔科斯基曾就围绕米非司酮获取渠道的政治压力询问过奥弗顿。健康委员会主席、路易斯安那州参议员比尔·卡西迪也拒绝置评。当被问及他的决定时,他说:“我是那种最后一秒才决定的人,”边笑边向后滑步离开记者群。
“I have not taken a position,” said Sen. Susan Collins of Maine in a brief interview on Capitol Hill on Thursday, adding that she needed “to get some answers on various things.”Sen. Lisa Murkowski of Alaska declined to say how she’d vote. During her confirmation hearing in September, Murkowski asked Overton about political pressure surrounding access to mifepristone. Sen. Bill Cassidy of Louisiana, the health committee’s chairman, also declined to comment. Asked about his decision, he said, “I’m a last-second sort of guy,” laughing as he moonwalked away from reporters.
但卡西迪一直公开表示怀疑。在奥弗顿的提名听证会之前,他在X平台上发文称对她的提名“有强烈担忧”,认为她缺乏管理经验,难以胜任领导该机构的工作。周三,卡西迪在一篇帖子中表示他仍未决定,并补充说他已与奥弗顿以及特朗普提名的国家科学基金会局长人选吉姆·奥尼尔进行了“几次坦诚交谈”,内容涉及“他们的愿景、角色,以及由于政府内其他官员违背承诺和做出不负责任的决定而导致的信任缺失。”
But Cassidy has been openly skeptical. Before Overton’s confirmation hearing, he wrote on X that he had “strong concerns” about her nomination, saying her lack of managerial experience left her poorly prepared to lead the agency. In a post Wednesday, Cassidy said he remained undecided, adding he’s had “several frank conversations” with Overton and Jim O’Neill, Trump’s nominee to serve as the director of the National Science Foundation, about “their visions, roles, and the lack of trust that exists due to broken promises and irresponsible decisions from other officials within the Administration.”
这些参议员在下周三的委员会表决前仍有可能被说服,白宫没有显示出打算撤回提名的迹象。白宫未回应置评请求。
The senators could still be won over before the committee vote next Wednesday, and the White House has given no indication that it plans to withdraw her nomination. The White House did not respond to a request for comment.
要在21人组成的委员会中推进至全院表决,奥弗顿需要获得11票支持,这意味着如果所有民主党人都反对她,她一个共和党人的票也输不起。随后,她还需通过参议院全院投票。时间也所剩无几。在中期选举中赢得参议院控制权的民主党人将于1月3日掌权。据一名前国会助手透露,如果到那时奥弗顿仍未获确认,她的提名极有可能被退回白宫,特朗普将不得不在民主党控制的参议院前再次提名她,届时她的获批前景将十分渺茫。
To advance to the full Senate, Overton needs 11 votes in the 21-member committee, which means she can’t afford to lose a single Republican if all Democrats oppose her. After that, she would need to pass a Senate vote. Time is also running short. Democrats, who won control of the Senate in the midterm elections, take power on Jan. 3. According to a former congressional aide, if Overton isn’t confirmed by then, her nomination would most likely be returned to the White House and Trump would have to nominate her again before a Democratic-controlled Senate, where her chances would be slim.
谁领导FDA,谁将面临一系列重大决策——从疫苗批准到米非司酮的安全性审查——而该机构自马蒂·马卡里博士于5月辞职以来一直没有常任局长。奥弗顿是一名预防医学医生,现任白宫国内政策官员。当特朗普签署一项旨在减少常规推荐给儿童的疫苗数量的行政令时,她曾出席陪同。在9月的确认听证会上,奥弗顿在疫苗问题上似乎与卫生部长小罗伯特·肯尼迪分道扬镳,称麻疹、腮腺炎和风疹疫苗安全有效。
Whoever leads the FDA will inherit a series of consequential decisions — from vaccine approvals to a safety review of mifepristone — at an agency that has been without a permanent commissioner since Dr. Marty Makary resigned in May. Overton, a preventive medicine doctor, is a domestic policy official in the White House. She appeared alongside Trump when he signed an executive order aimed at reducing the number of vaccines routinely recommended for children. At her confirmation hearing in September, Overton appeared to break with Health Secretary Robert F. Kennedy Jr. on vaccines, calling the measles, mumps and rubella vaccine safe and effective.
但她在堕胎问题上的记录引来民主党人的严厉审视。在保守派智库“美国优先政策研究所”任职期间,她曾称FDA允许米非司酮邮寄送达的决定“对女性有危险”。该机构目前正在对该药物进行安全性审查,若奥弗顿获任命为局长,将由她监督这一审查。听证会期间,她避而不谈米非司酮相关问题,仅表示该药物符合FDA标准,且她不愿预判机构的审查结果。
But her record on abortion has drawn intense scrutiny from Democrats. While working at the American First Policy Institute, a conservative think tank, she called the FDA’s decision to allow mail delivery of mifepristone “dangerous to women.”The agency is now conducting a safety review of the drug, which Overton would oversee as commissioner. During the hearing, she sidestepped questions on mifepristone, saying only that it had met the FDA’s standards and that she didn’t want to prejudge the agency’s review.